Fintech

Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meet

Prnewswire·April 9, 2026 at 11:45 AM

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present six abstracts, including one oral presentation, at the...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

Treasury Shares Cybersecurity Intel with Crypto Firms
PYMNTS
New Stablecoin Rules Affect Banks and FinTechs
PYMNTS
HOA fees strain household budgets
PYMNTS
Anthropic launches AI agents product
PYMNTS

Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meet

Treasury Shares Cybersecurity Intel with Crypto Firms

New Stablecoin Rules Affect Banks and FinTechs

HOA fees strain household budgets

Anthropic launches AI agents product